These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 10932925)
61. Niacin in patients with diabetes mellitus and coronary artery disease. Lavie CJ; Milani RV Am J Cardiol; 2001 May; 87(9):1137-8. PubMed ID: 11396426 [No Abstract] [Full Text] [Related]
62. Progression to hepatitis and fibrosis secondary to lomitapide use: selecting the next course of action. Miyares MA JAMA Intern Med; 2014 Sep; 174(9):1522. PubMed ID: 25178868 [No Abstract] [Full Text] [Related]
63. Progression to hepatitis and fibrosis secondary to lomitapide use--reply. Sacks FM; Stanesa M; Hegele RA JAMA Intern Med; 2014 Sep; 174(9):1522-3. PubMed ID: 25178869 [No Abstract] [Full Text] [Related]
66. [Treatment of hypertriglyceridemia. Current aspects]. Malaguarnera M; Giugno I; Ruello P; Vinci E; Panebianco MP; Motta M Recenti Prog Med; 2000; 91(7-8):379-87. PubMed ID: 10932925 [TBL] [Abstract][Full Text] [Related]
67. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Breuer HW Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448 [TBL] [Abstract][Full Text] [Related]
69. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management. Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582 [TBL] [Abstract][Full Text] [Related]
70. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276 [TBL] [Abstract][Full Text] [Related]